Synergy Innovation Co. Ltd Market Cap ($80.73 Million)
Market Cap & Net Worth: Synergy Innovation Co. Ltd (048870)
Synergy Innovation Co. Ltd market cap. Synergy Innovation Co. Ltd (KQ:048870) has a market capitalization of $80.73 Million (₩119.12 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #19832 globally and #1029 in its home market, demonstrating a -1.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Synergy Innovation Co. Ltd's stock price ₩1352.00 by its total outstanding shares 88106963 (88.11 Million). Also see how efficiently does Synergy Innovation Co. Ltd generate cash for how efficiently the company converts equity into cash flow.
Synergy Innovation Co. Ltd Market Cap History (2015–2026)
Synergy Innovation Co. Ltd market cap history from 2015 to 2026. Data shows growth from $259.00 Million to $80.73 Million (2.12% CAGR). Check 048870 stock price for real-time trading data and today's change.
Index Memberships
Synergy Innovation Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.04% | #428 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.04% | #428 of 1384 |
Weight: Synergy Innovation Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Synergy Innovation Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Synergy Innovation Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 048870 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Synergy Innovation Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.05x
Synergy Innovation Co. Ltd's market cap is 0.05 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $142.11 Million | $15.62 Billion | $13.67 Billion | 0.01x | 0.01x |
| 2017 | $120.01 Million | $34.20 Billion | -$9.28 Billion | 0.00x | N/A |
| 2018 | $122.40 Million | $42.05 Billion | -$1.35 Billion | 0.00x | N/A |
| 2019 | $128.97 Million | $54.59 Billion | $3.35 Billion | 0.00x | 0.04x |
| 2020 | $219.13 Million | $68.95 Billion | -$21.41 Billion | 0.00x | N/A |
| 2021 | $257.35 Million | $30.71 Billion | $5.72 Billion | 0.01x | 0.04x |
| 2022 | $166.59 Million | $86.54 Billion | $16.13 Billion | 0.00x | 0.01x |
| 2023 | $163.01 Million | $83.21 Billion | $2.30 Billion | 0.00x | 0.07x |
| 2024 | $154.94 Million | $90.61 Billion | $10.37 Billion | 0.00x | 0.01x |
| 2025 | $140.02 Million | $113.05 Billion | $3.01 Billion | 0.00x | 0.05x |
Competitor Companies of 048870 by Market Capitalization
Companies near Synergy Innovation Co. Ltd in the global market cap rankings as of November 4, 2026. Also see 048870 asset base for a full breakdown of the balance sheet.
Key companies related to Synergy Innovation Co. Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Synergy Innovation Co. Ltd (2015–2026)
Market capitalization of Synergy Innovation Co. Ltd from 2015 to today. Between 2015 and today, Synergy Innovation Co. Ltd's market cap moved from $259.00 Million to $ 80.73 Million, with a yearly change of 2.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩80.73 Million | -42.35% |
| 2025 | ₩140.02 Million | -9.63% |
| 2024 | ₩154.94 Million | -4.95% |
| 2023 | ₩163.01 Million | -2.15% |
| 2022 | ₩166.59 Million | -35.27% |
| 2021 | ₩257.35 Million | +17.44% |
| 2020 | ₩219.13 Million | +69.91% |
| 2019 | ₩128.97 Million | +5.37% |
| 2018 | ₩122.40 Million | +1.99% |
| 2017 | ₩120.01 Million | -15.55% |
| 2016 | ₩142.11 Million | -45.13% |
| 2015 | ₩259.00 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Synergy Innovation Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $80.73 Million USD |
| MoneyControl | $80.73 Million USD |
| MarketWatch | $80.73 Million USD |
| marketcap.company | $80.73 Million USD |
| Reuters | $80.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Synergy Innovation Co. Ltd
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more